CLINICAL_TRIALS
trial_result
· 2018-06-27
Clinical Trial Update: Trial II of Lung Protection With Azithromycin in the Preterm Infant [Phase 2]
Summary
A Phase 2 trial update reporting results of azithromycin for lung protection in preterm infants at risk of bronchopulmonary dysplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hubert Ballard | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: COMPLETED | Results posted: 2018-06-27